Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2009
07/09/2009US20090176780 Nitrogenous heterocyclic compounds
07/09/2009US20090176774 Compounds and methods of use
07/09/2009US20090176771 Gyrase inhibitors and uses thereof
07/09/2009US20090176765 Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp)
07/09/2009US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
07/09/2009US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases
07/09/2009US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis
07/09/2009US20090176716 Inhibitors of cancer cell, t-cell and keratinocyte proliferation
07/09/2009US20090175809 Merocyanine derivatives for cosmetic use
07/09/2009CA2710959A1 Imidazole carbonyl compounds and use thereof for treating bacterial infections
07/09/2009CA2710092A1 Pyridazinone derivatives
07/09/2009CA2707520A1 Herbicidal pyridazinone derivatives
07/08/2009EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
07/08/2009EP2076496A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
07/08/2009EP2076495A1 Quinoline derivatives with 5-ht-binding properties
07/08/2009EP2076128A2 Protein kinase inhibitors and methods for using thereof
07/08/2009EP1753744B1 Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors
07/08/2009EP1635821B1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
07/08/2009EP1592686B1 Gyrase inhibitors and uses thereof
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/08/2009CN101475565A Anti-hypertension compound, and preparation, pharmaceutical composition and use thereof
07/08/2009CN101475564A Novel preparation of losartan potassium
07/08/2009CN101475563A 3-amino-4-indole-N-methyl maleimide compound, preparation and use thereof
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509813C Hetereoaryl nitrile derivative
07/08/2009CN100509802C Heteroaryl deravatives as PPAR activators
07/08/2009CN100509801C HIV inhibiting pyrimidines derivatives
07/08/2009CN100509800C Candesartan Cilexetil and precursor compound preparation method thereof
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
07/08/2009CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease
07/08/2009CN100509782C NK* antagonists
07/07/2009US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
07/07/2009US7557221 Substituted hydantoins
07/07/2009US7557220 Tetrazole based linear polymers
07/07/2009US7557210 Antiinflamamtory agents
07/07/2009US7557137 Gamma-lactams as beta-secretase inhibitors
07/07/2009US7557136 Pyrrolidine derivatives as oxytocin antagonists
07/07/2009US7557127 HDAC inhibitor
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557115 Compounds for modulation of kinesins as anticancer agents with administering
07/07/2009US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide
07/07/2009US7557102 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
07/07/2009US7557098 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
07/07/2009CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
07/07/2009CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
07/07/2009CA2450033C Viral polymerase inhibitors
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/07/2009CA2422711C Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
07/07/2009CA2378834C Pyrazinones, compositions containing such compounds
07/02/2009WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
07/02/2009WO2009082346A1 New acetyl coenzyme a carboxylase (acc) inhibitors and uses in treatments of obesity and diabetes mellitus - 087
07/02/2009WO2009081718A1 Triazole derivative, light-emitting element, light-emitting device, and electronic device
07/02/2009WO2009081195A1 Carbamoyl compounds as dgat1 inhibitors 190
07/02/2009WO2009081105A2 Quinoxaline and quinoline derivatives as kinase inhibitors
07/02/2009WO2009080744A1 Crystalline form of azelastine
07/02/2009WO2009080689A1 Intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes
07/02/2009WO2009080542A1 Process for the preparation of a macrocycle
07/02/2009WO2009080366A1 A process of making imatinib
07/02/2009WO2009080227A2 Pyrazole-carboxamide derivatives as p2y12 antagonists
07/02/2009WO2009080226A2 Heterocyclic pyrazole-carboxamides as p2y12 antagonists
07/02/2009WO2009079797A1 Compounds and method for treatment of cancer
07/02/2009WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/02/2009WO2009064836A3 Kynurenine-aminotransferase inhibitors
07/02/2009WO2009064802A3 Inhibitors of human phosphatidyl-inositol 3-kinase delta
07/02/2009WO2009049305A3 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer
07/02/2009WO2009016410A3 Chemical compounds 831
07/02/2009US20090171097 Automated solid phase synthesis of pyrrole-imidazole polyamide
07/02/2009US20090171086 2,4-pyrimidinediamine compounds and their uses
07/02/2009US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
07/02/2009US20090171075 Molecular transporter compositions comprising dendrimeric oligoguanidine with a triazine core that facilitate delivery into cells in vivo
07/02/2009US20090170922 Benzimidazole derivatives and their use as a medicament
07/02/2009US20090170921 Benzimidazole derivatives
07/02/2009US20090170920 Substituted hydantoins
07/02/2009US20090170898 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170875 Compounds for the treatment of inflammatory disorders
07/02/2009US20090170874 Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
07/02/2009US20090170872 Compounds and Their Pharmaceutical Use
07/02/2009US20090170861 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors
07/02/2009US20090170859 Viral Polymerase Inhibitors
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170835 Isoindoline derivatives
07/02/2009US20090170833 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
07/02/2009US20090170832 HETEROCYCLIC COMPOUNDS HAVING TYPE I 11beta HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
07/02/2009US20090170828 Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
07/02/2009US20090170812 Transcription factor modulating compounds and methods of use thereof
07/02/2009US20090170734 Novel imidazolinium salts with low melting point, processes for preparation thereof and use thereof as a lubricant
07/02/2009US20090167166 Materials for organic electroluminescent devices
07/02/2009CA2710118A1 Sulfamides as zap-70 inhibitors
07/02/2009CA2710039A1 Compounds and method for treatment of cancer
07/02/2009CA2709536A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/02/2009CA2709032A1 Process for the preparation of a macrocycle
07/02/2009CA2708502A1 Perhydroquinoxaline derivatives
07/02/2009CA2707660A1 Carbamoyl compounds as dgat1 inhibitors 190
07/02/2009CA2707333A1 Crystalline form of azelastine
07/01/2009EP2075249A2 Indolylmaleimide derivatives
07/01/2009EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/01/2009EP2074114A1 Pyrimidinones as casein kinase ii (ck2) modulators
07/01/2009EP2074113A1 Indazolyl derivatives useful as potassium channel modulating agents
07/01/2009EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers